Drug maker reaches settlement
LANSING — Michigan is expected to get nearly $3.4 million from a multi-state settlement with a pharmaceutical company.
Attorney General Bill Schuette said this month that the money is part of a $125-million national settlement with Cephalon.
Part of the money will go to Michigan consumers who bought the drug Provigil.
The settlement ends a multi-state investigation into conduct by Cephalon that delayed generic versions of Provigil from entering the market for years, causing consumers to pay higher prices.
The company denied wrongdoing.
The settlement is subject to court review.